BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Battistini L, Bugatti K, Sartori A, Curti C, Zanardi F. RGD Peptide‐Drug Conjugates as Effective Dual Targeting Platforms: Recent Advances. Eur J Org Chem 2021;2021:2506-28. [DOI: 10.1002/ejoc.202100240] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Torcasio SM, Oliva R, Montesi M, Panseri S, Bassi G, Mazzaglia A, Piperno A, Coulembier O, Scala A. Three-armed RGD-decorated starPLA-PEG nanoshuttle for docetaxel delivery. Biomaterials Advances 2022;140:213043. [DOI: 10.1016/j.bioadv.2022.213043] [Reference Citation Analysis]
2 Migliorini F, Cini E, Dreassi E, Finetti F, Ievoli G, Macrì G, Petricci E, Rango E, Trabalzini L, Taddei M. A pH-responsive crosslinker platform for antibody-drug conjugate (ADC) targeting delivery. Chem Commun (Camb) 2022. [PMID: 36043993 DOI: 10.1039/d2cc03052g] [Reference Citation Analysis]
3 Chen Y, Jia L, Zhu G, Wang W, Geng M, Lu H, Zhang Y, Zhou M, Zhang F, Cheng X. Sortase A-mediated cyclization of novel polycyclic RGD peptides for ανβ3 integrin targeting. Bioorg Med Chem Lett 2022;73:128888. [PMID: 35839966 DOI: 10.1016/j.bmcl.2022.128888] [Reference Citation Analysis]
4 Bugatti K, Andreucci E, Monaco N, Battistini L, Peppicelli S, Ruzzolini J, Curti C, Zanardi F, Bianchini F, Sartori A. Nintedanib-Containing Dual Conjugates Targeting αVβ6 Integrin and Tyrosine Kinase Receptors as Potential Antifibrotic Agents. ACS Omega 2022;7:17658-69. [PMID: 35664627 DOI: 10.1021/acsomega.2c00535] [Reference Citation Analysis]
5 Echavidre W, Picco V, Faraggi M, Montemagno C. Integrin-αvβ3 as a Therapeutic Target in Glioblastoma: Back to the Future? Pharmaceutics 2022;14:1053. [DOI: 10.3390/pharmaceutics14051053] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Paulus J, Sewald N. Synthesis and Evaluation of a Non-Peptide Small-Molecule Drug Conjugate Targeting Integrin αVβ3. Front Chem 2022;10:869639. [DOI: 10.3389/fchem.2022.869639] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Jalil AR, Andrechak JC, Hayes BH, Chenoweth DM, Discher DE. Human CD47-Derived Cyclic Peptides Enhance Engulfment of mAb-Targeted Melanoma by Primary Macrophages. Bioconjug Chem 2022. [PMID: 35285229 DOI: 10.1021/acs.bioconjchem.2c00020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]